Vascularized Encapsulation for Closed-Loop Blood Glucose Regulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing technologies for regulating blood glucose, such as implantable devices with glucose sensors and insulin infusion systems, face challenges in accurately sensing glucose levels and efficiently delivering insulin due to limitations in oxygen supply and integration with the body's vascular system, leading to suboptimal sensor performance and insulin release kinetics.
Innovation Solution
The development of vascularized encapsulation devices with integrated glucose sensors and optional insulin secreting cells, connected to an insulin infusion pump, which include oxygen delivery mechanisms to enhance sensor accuracy and longevity, and a closed-loop control system for insulin release based on glucose levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If implantable devices with glucose sensors and insulin infusion systems are used, then blood glucose regulation is achieved, but sensor performance and insulin release kinetics are suboptimal due to limitations in oxygen supply and integration with the body's vascular system
Solution Approach 1:
The glucose sensor is nested within the vascularized encapsulation device, which provides a dedicated vascular network for oxygen and nutrient supply. This nested structure allows the sensor to benefit from the vascularization without requiring external oxygen supply systems, thereby improving sensor performance and longevity while maintaining implantability.
Solution Approach 2:
The encapsulation device is pre-vascularized before implantation, establishing a functional vascular network in advance. This preliminary vascularization ensures adequate oxygen supply to the glucose sensor and insulin-secreting cells from the moment of implantation, eliminating the suboptimal performance caused by oxygen deprivation that would otherwise occur in non-vascularized implantable devices.
2Productivity
If implantable devices with glucose sensors and insulin infusion systems are used, then blood glucose regulation is achieved, but insulin release kinetics are suboptimal due to limitations in oxygen supply and integration with the body's vascular system
Solution Approach 1:
The insulin-secreting cells are nested within the vascularized encapsulation device, ensuring they receive adequate oxygen and nutrients through the integrated vascular network. This improves their metabolic activity and insulin secretion kinetics, allowing for more efficient and responsive insulin release in response to glucose fluctuations compared to non-vascularized systems.
Solution Approach 2:
The device is pre-vascularized to establish oxygen supply pathways before the insulin-secreting cells are introduced. This preliminary vascularization ensures that the cells immediately upon implantation receive sufficient oxygen to maintain optimal metabolic function and insulin release kinetics, rather than suffering from oxygen deprivation that would slow down their productivity.
3Device complexity
If non-vascularized encapsulation devices are used, then device complexity is reduced, but integration with the body's vascular system is poor leading to suboptimal sensor performance
Solution Approach 1:
The vascularized encapsulation device is designed to self-vascularize through the body's natural angiogenic processes. The device structure includes features that promote blood vessel ingrowth, allowing the body's own vascular system to automatically integrate with the device without requiring complex external vascular connections or surgical intervention. This self-service approach improves sensor performance through adequate oxygen supply while avoiding excessive device complexity.
Data Source
AI summary
Methods, systems, and devices for regulating blood glucose such as implantable encapsulated devices optionally with insulin and/or glucagon secreting cells in combination with glucose sensors and insulin infusion systems. For example, encapsulation devices may be connected to an insulin infusion pump for distribution of insulin. The insulin infusion pump may feature an insulin pouch fluidly connected to an insulin pump (or a syringe) and a glucose sensor separate from the encapsulation device. The system may feature an additional implantable device comprising insulin and glucagon secreting cells.